Hino, Japan

Kensaku Takanashi

This inventor holds 19 USPTO granted patents and 7 published patent applications and 13 EPO patents, primarily in Biological Detection Technology. Top assignees: Konica Minolta, Inc., Konica Minolta Medical and Graphic, Inc., Tohoku University. Active years: 2014-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kensaku Takanashi. Retrieved from https://idiyas.com/inventor/kensaku-takanashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Tokyo, JP (2016)
  • Hachioji, JP (2014 - 2022)
  • Hino, JP (2018 - 2022)

Company Filing History:


Years Active: 2014-2022

Loading Chart...
Loading Chart...
Areas of Expertise:
Aminocoumarin Compound
Fluorescent Nanoparticles
Biological Substance Detection
Pathological Diagnosis
Tissue Staining
Dye-Containing Resin
Biomolecular Staining
Image Processing Device
Quantifying Method
Labeling Agent
Thermosetting Resin
Semiconductor Nanoparticle
19 patents (USPTO):Explore Patents

Title: Innovations by Kensaku Takanashi - Pioneering Aminocoumarin Compounds

Introduction

Kensaku Takanashi, a Japanese inventor based in Hino, has made significant contributions to the field of chemistry with a total of 19 patents to his name. His innovative work primarily revolves around the development of aminocoumarin compounds, which have practical applications in biological detection methods.

Latest Patents

Among his latest patents are groundbreaking developments in aminocoumarin compounds and aminocoumarin compound-containing resin particles. The first patent details an aminocoumarin compound with a unique structure. This compound serves as a fluorescent dye, with a longer excitation wavelength compared to traditional sulfonated coumarin-based compounds, effectively excited at wavelengths of 475 nm or higher. The secondary patent focuses on a method for biological substance detection that utilizes a fluorescent label for identifying specific substances in pathological specimens. This method enhances the clarity and observation of tissue morphology while ensuring precise detection through specialized fluorescent particles.

Career Highlights

Kensaku Takanashi has had a prominent career, notably at Konica Minolta, Inc. and Konica Minolta Medical and Graphic, Inc. His position at these companies enabled him to pursue innovative research and development, particularly in the integration of fluorescent dyes in medical applications.

Collaborations

Throughout his career, Takanashi has collaborated with esteemed colleagues, including Yasushi Nakano and Kohsuke Gonda. These collaborations have fostered an environment of innovation, allowing for the exploration and advancement of new technologies in the field of biomedical research.

Conclusion

Kensaku Takanashi's contributions to the field of inventions, particularly through his patents involving aminocoumarin compounds, illustrate his commitment to advancing scientific knowledge and technology. His work not only enhances our understanding of biological detection methods but also underscores the importance of collaboration in achieving significant breakthroughs in research and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…